You have 9 free searches left this month | for more free features.

City

Guangzhou (1)

Tianjin (1)

Condition

Acute Myeloid Leukemia (1)

Autologous Hematopoietic Stem Cell Transplantation (1)

B-cell Childhood Acute Lymphoblastic Leukemia (1)

Childhood Acute Lymphoblastic Leukemia (1)

Conditioning (1)

Philadelphia Chromosome, Ph^1^, Absent (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 2/phase 3 (1)

phase 4 (1)

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)

Nanfang Hospital of Southern Medical University (1)

Collaborator

Guangzhou First People's Hospital (1)

Peking University People's Hospital (1)

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Third Affiliated Hospital, Sun Yat-Sen University (1)

Zhujiang Hospital (1)

Intervention

idarubicin(ida) (2)

busulfan (bu) (1)

cyclophosphamide (cy) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

idarubicin(ida)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Autologous Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Conditioning Trial in Guangzhou (Idarubicin(IDA),

Completed

Autologous Hematopoietic Stem Cell Transplantation
+2 more

Idarubicin（IDA）
+2 more

Guangzhou, Guangdong, China

Department of Hematology,Nanfang Hospital, Southern Medical Univ

Mar 2, 2020

Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent, B-cell Childhood Acute Lymphoblastic Leukemia

Unknown status

Childhood Acute Lymphoblastic Leukemia
+2 more

Idarubicin(IDA)

Tianjin, Tianjin, China

Department of Pediatrics, Institute of Hematology and Blood Dise

Nov 20, 2013